Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Tofacitinib might be used to treat hair loss.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

PCFCL may have unrecognized subtypes and needs more research.

High-dose iron therapy improves anemia without affecting IBD treatment.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

S1PR1 helps control inflammation in blood vessel cells by affecting gene activity differently in various cell types and locations.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Hair follicle stem cell transplants can reverse liver cirrhosis by blocking harmful cell activation.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Fzd2 is important for skin and hair development through various signaling ways.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.